Staging and Follow-up of Ovarian Cancer
暂无分享,去创建一个
H. Pannu | D. Mitchell | M. Harisinghani | J. Wong-You-Cheong | T. Shipp | P. Glanc | C. Zelop | H. Royal | Pandharipande | Robert | Douglas L. Brown | Pari | G. Bennett | M. Javitt | C. Siegel | A. Podrasky | S. | V. | Neil | Harris | Ted Dubinsky | D. | M. S. K. Stella K. Kang | MD b Caroline Reinhold | MD c Mostafa Atri | MD e Carol B. Benson | MD e Priyadarshani R. Bhosale | MD g Yulia Lakhman | MD MS h Katherine E. Maturen | D. M. Refky Nicola | Pari | M. M. J. V. Pandharipande | MD k Gloria M. Salazar | M. R. Thomas D. Shipp | MD n Lynn Simpson | MD William Small Jr | MD o Betsy L. Sussman | MD p Jennifer W. Uyeda | MD q Darci J. Wall | MD r Bradford P. Whitcomb | MD s Carolyn M. Zelop | MD h Phyllis Glanc | Horowitz | Lynn Simpson | MD Stella K. Kang | MD Anuja Jhingran | MD Katherine E. Maturen
[1] Sanjiv S Gambhir,et al. Early diagnosis of ovarian carcinoma: is a solution in sight? , 2011, Radiology.
[2] Hongju Son,et al. Role of FDG PET/CT in staging of recurrent ovarian cancer. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.
[3] H. Hricak,et al. Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: effect on survival. , 2011, Radiology.
[4] G. Hall,et al. Clinical utility of image-guided peritoneal and omental biopsy , 2010, Nature Reviews Clinical Oncology.
[5] J. Micha,et al. The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review , 2010, British Journal of Cancer.
[6] H. Hricak,et al. Prognostic Significance of Supradiaphragmatic Lymphadenopathy Identified on Preoperative Computed Tomography Scan in Patients Undergoing Primary Cytoreduction for Advanced Epithelial Ovarian Cancer , 2010, International Journal of Gynecologic Cancer.
[7] Jae Hoon Kim,et al. Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI. , 2010, Gynecologic oncology.
[8] A. Loft,et al. Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer? , 2010, Gynecologic oncology.
[9] Diane M Twickler,et al. Ultrasound and assessment of ovarian cancer risk. , 2010, AJR. American journal of roentgenology.
[10] D Timmerman,et al. Confidence of expert ultrasound operators in making a diagnosis of adnexal tumor: effect on diagnostic accuracy and interobserver agreement , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[11] H. Hricak,et al. Follow-Up Study of the Correlation Between Postoperative Computed Tomographic Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, or Peritoneal Carcinoma Reported to Have Undergone Primary Surgical Cytoreduction to Residual Disease of 1 cm or Smaller , 2009, International Journal of Gynecologic Cancer.
[12] M. Riquet,et al. Role of Video-Assisted Thoracoscopy in Patients With Ovarian Cancer and Pleural Effusion , 2009, International Journal of Gynecologic Cancer.
[13] R. Low,et al. Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings--a feasibility study. , 2009, AJR. American journal of roentgenology.
[14] J. W. Kim,et al. The role of serum CA-125 levels in early-stage epithelial ovarian cancer on preoperative CT and MRI. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[15] A. Gadducci,et al. Are Surveillance Procedures of Clinical Benefit for Patients Treated for Ovarian Cancer?: A Retrospective Italian Multicentric Study , 2009, International Journal of Gynecologic Cancer.
[16] S. Steinberg,et al. Lack of reliability of CA125 response criteria with anti‐VEGF molecularly targeted therapy , 2008, Cancer.
[17] A. De Gaetano,et al. A Treatment Selection Protocol for Recurrent Ovarian Cancer Patients: The Role of FDG-PET/CT and Staging Laparoscopy , 2008, Oncology.
[18] K. Sugimura,et al. Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[19] H. Hricak,et al. Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion. , 2008, Radiology.
[20] C. Cuénod,et al. Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. , 2008, Radiology.
[21] L. Turnbull,et al. The accurate staging of ovarian cancer using 3T magnetic resonance imaging – a realistic option , 2008, BJOG : an international journal of obstetrics and gynaecology.
[22] K. Hillaby,et al. Effect of quality of gynaecological ultrasonography on management of patients with suspected ovarian cancer: a randomised controlled trial. , 2008, The Lancet. Oncology.
[23] A. Loft,et al. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography--a prospective study. , 2008, Gynecologic oncology.
[24] F. Fazio,et al. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histology , 2007, Nuclear medicine communications.
[25] Yu-feng Xu,et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis of ovarian carcinoma. , 2007, European journal of radiology.
[26] N. Avril,et al. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer. , 2007, Gynecologic oncology.
[27] J. McAlpine,et al. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. , 2007, Gynecologic oncology.
[28] B. Karlan,et al. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] J. Spencer,et al. Women with peritoneal carcinomatosis of unknown origin: efficacy of image‐guided biopsy to determine site‐specific diagnosis , 2006, BJOG : an international journal of obstetrics and gynaecology.
[30] T. Miyamoto,et al. Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer , 2005, International Journal of Gynecologic Cancer.
[31] Hedvig Hricak,et al. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. , 2005, Gynecologic oncology.
[32] R. Kryscio,et al. Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography. , 2003, Gynecologic oncology.
[33] K. Horton,et al. Thin Section Dual‐Phase Multidetector‐Row Computed Tomography Detection of Peritoneal Metastases in Gynecologic Cancers , 2003, Journal of computer assisted tomography.
[34] S. Jung,et al. CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. , 2002, Radiographics : a review publication of the Radiological Society of North America, Inc.
[35] S. Reske,et al. Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings. , 2002, Radiology.
[36] R. Agid,et al. Value of chest CT scans in routine ovarian carcinoma follow-up. , 2001, AJR. American journal of roentgenology.
[37] K. Nuessle,et al. Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings. , 2001, AJR. American journal of roentgenology.
[38] K. Togashi,et al. Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. , 2001, AJR. American journal of roentgenology.
[39] A. Dachman,et al. Role of chest CT in the follow-up of ovarian adenocarcinoma. , 2001, AJR. American journal of roentgenology.
[40] H. Hricak,et al. US characterization of ovarian masses: a meta-analysis. , 2000, Radiology.
[41] E K Outwater,et al. Imaging evaluation of ovarian masses. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.
[42] D. Maulik,et al. Simple cyst in the postmenopausal patient: detection and management. , 1998, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[43] H. Hricak,et al. Ovarian cancer: staging with CT and MR imaging. , 1995, Radiology.
[44] R. Zepp,et al. Ovarian carcinoma: value of CT in predicting success of debulking surgery. , 1995, AJR. American journal of roentgenology.
[45] S. Orsulic,et al. Ovarian Cancer , 1993, British Journal of Cancer.
[46] J. Grudzinskas,et al. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. , 1993, BMJ.
[47] M. Bazot,et al. Epithelial tumors of the ovary: comparison of MR and CT findings. , 1991, Radiology.
[48] M. Bazot,et al. Epithelial tumors of the ovary: CT findings and correlation with US. , 1991, Radiology.
[49] K. Olesen,et al. Correlation of abdominal ultrasound and computed tomography scans with second‐ or third‐look laparotomy in patients with ovarian carcinoma , 1991, Gynecologic oncology.
[50] K. Reuter,et al. Comparison of abdominopelvic computed tomography results and findings at second‐look laparotomy in ovarian carcinoma patients , 1989, Cancer.
[51] P. Silverman,et al. CT prior to second-look operation in ovarian cancer. , 1988, AJR. American journal of roentgenology.
[52] A. Megibow,et al. Accuracy of CT in detection of persistent or recurrent ovarian carcinoma: correlation with second-look laparotomy. , 1988, Radiology.
[53] M. Sharma,et al. Pre-operative evaluation of peritoneal deposits using multidetector computed tomography in ovarian cancer. , 2011, The British journal of radiology.
[54] L. Tanoue. Cancer Statistics, 2009 , 2010 .
[55] P. Lumbiganon,et al. Interval debulking surgery for advanced epithelial ovarian cancer: a Cochrane systematic review. , 2009, Gynecologic oncology.
[56] Sukru Mehmet Erturk,et al. Predictive value of percutaneous imaging-guided biopsy of peritoneal and omental masses: results in 111 patients. , 2009, AJR. American journal of roentgenology.
[57] H. Earl,et al. Image-guided biopsy in patients with suspected ovarian carcinoma: a safe and effective technique? , 2008, European Radiology.
[58] A. Fischman,et al. PET–CT vs. CT alone in ovarian cancer recurrence , 2007, Abdominal Imaging.
[59] Y. Yonekura,et al. Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer. , 2004, AJR. American journal of roentgenology.
[60] P. Woodward,et al. From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.
[61] H. Hricak,et al. Complex adnexal masses: detection and characterization with MR imaging--multivariate analysis. , 2000, Radiology.
[62] R. Semelka,et al. Primary ovarian cancer: Prospective comparison of contrast‐enhanced CT and pre‐and postcontrast, fat‐ suppressed MR imaging, with histologic correlation , 1993, Journal of magnetic resonance imaging : JMRI.
[63] P. Schwartz,et al. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.